Nexalin Technology (NXL) Retained Earnings (2021 - 2026)
Nexalin Technology (NXL) recorded quarterly Retained Earnings of $494.0 in Q1 2026, up 21.67% quarter-over-quarter from $406.0 in Q4 2025, and up 55.84% on a YoY basis from $317.0 in Q1 2025.
Nexalin Technology (NXL) Retained Earnings (2021 - 2026) Analysis & Trends
Nexalin Technology's Retained Earnings history runs 6 years deep, the most recent figure standing at $494.0 for Q1 2026.
- In Q1 2026, Retained Earnings rose 55.84% year-over-year to $494.0; the TTM figure through Mar 2026 stood at $494.0 (up 55.84% YoY), while the FY2025 annual figure was $406.0, up 100.0% from the prior year.
- Retained Earnings was $494.0 for Q1 2026 at Nexalin Technology, up from $406.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $41069.0 in Q1 2023 to a low of -$90.5 million in Q3 2025.
- Historically, Retained Earnings has averaged -$47.2 million across 5 years, with a median of -$72.4 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings plunged 100.6% in 2024, then surged 229.39% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$72.4 million in 2022, then dropped by 6.42% to -$77.0 million in 2023, then dropped by 9.87% to -$84.6 million in 2024, then surged by 100.0% to $406.0 in 2025, then rose by 21.67% to $494.0 in 2026.
- The last three Retained Earnings figures came in at $494.0 (Q1 2026), $406.0 (Q4 2025), and -$90.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 49.96 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 32.30 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -398.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -221.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 106.20 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 5.65 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -113.10 Mn |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 | 494.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 494.00 |
| Dec 31, 2025 | 406.00 |
| Sep 30, 2025 | -90.49 Mn |
| Jun 30, 2025 | 830.00 |
| Mar 31, 2025 | 317.00 |
| Dec 31, 2024 | -84.65 Mn |
| Sep 30, 2024 | -81.81 Mn |
| Jun 30, 2024 | -79.36 Mn |
| Mar 31, 2024 | -245.00 |
| Dec 31, 2023 | -77.04 Mn |
| Sep 30, 2023 | -76.26 Mn |
| Jun 30, 2023 | -73.96 Mn |
| Mar 31, 2023 | 41,069.00 |
| Dec 31, 2022 | -72.39 Mn |
| Sep 30, 2022 | -71.66 Mn |
| Dec 31, 2021 | -70.69 Mn |